The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer

Cancer Research

Volumn 59, Issue 5, 1999, Pages 1015-1020

  Haiman, Christopher A ^a,c   Hankinson, Susan E ^a,c   Spiegelman, Donna ^a   Colditz, Graham A ^a,c   Willett, Walter C ^a,c   Speizer, Frank E ^a,c   Kelsey, Karl T ^a,b,c   Hunter, David J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID HORMONE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; FEMALE; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC RISK; GENETIC TRANSCRIPTION; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ANDROGENS; BREAST NEOPLASMS; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MENARCHE; MIDDLE AGED; NURSES; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE; UNITED STATES;

EID: 0033104346     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bernstein, L., and Ross, R. K. Endogenous hormones and breast cancer. Epidemiol. Rev., 15: 48-65, 1993.
2. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. Increased cell division as a cause of human cancer. Cancer Res., 50: 7415-7421, 1990.
3. Colditz, G. A. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst., 90: 814-823, 1998.
4. Tsai, M. J., and O'Malley, B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily. Annu. Rev. Biochem., 63: 451-486, 1994.
5. Beato, M. Gene regulation by steroid hormones. Cell. 56: 335-344, 1989.
6. Key, T. J. A., and Pike, M. C. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur. J. Cancer Clin. Oncol., 24: 29-43, 1988.
7. Kelsey, J. L. Breast cancer epidemiology: summary and future directions. Epidemiol. Rev., 15: 256-263, 1993.
8. Hsieh, C. C., Trichopoulos, D., Katsouyanni, K., and Yuasa, S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int. J. Cancer. 46: 796-800, 1990.
9. Hankinson, S. E., Willett, W. C., Manson, J. E., Hunter, D. J., Colditz, G. A., Stampfer, M. J., Longcope, C., and Speizer, F. E. Alcohol, height and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J. Natl. Cancer Inst., 87: 1297-1302, 1995.
10. Perel, E., and Killinger, D. W. The interconversion and aromatization of androgens by human adipose tissue. J. Steroid Biochem., 10: 623-627, 1979.
11. Sourdaine, P., Mullen, P., White, R., Telford, J., Parker, M. G., and Miller, M. R. Aromatase activity and CYP19 gene expression in breast cancers. J. Steroid Biochem. Mol. Biol., 59: 191-198, 1996.
12. Khan, S. A., Rodgers, M. A., Khurana, K. K., Meguid, M. M., and Numann, P. J. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J. Natl. Cancer Inst., 90: 37-42, 1998.
13. Picado-Leonard, J., and Miller, W. L. Cloning and sequence of the human gene for P450c17 (steroid 17α-hydroxylase/17,20-lyase): similarity with the gene for P450c21. DNA, 6: 439-448, 1987.
14. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., and Henderson, B. E. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res., 57: 1063-1065, 1997.
15. Zuber, M. X., Simpson, E. R., and Waterman, M. R. Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in nonsteroidogenic (Cos 1) cells. Science (Washington DC), 234: 1258-1261, 1986.
16. Yanase, T. 17α-Hydroxylase/17.20-lyase defects. J. Steroid Biochem. Mol. Biol., 53: 153-157, 1995.
17. Weston, A., Pan. C., Bleiweiss, I. J., Ksieski, H. B., Roy, N., Maloney, N., and Wolff, M. S. CYP17 genotype and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 7: 941-944, 1998.
18. Dunning, A. M., Healey, C. S., Pharoah, P. D. P., Foster, N. A., Lipscombe, J. M., Redman, K. L., Easton, D. F., Day, N. E., and Ponder, B. A. J. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br. J. Cancer, 77: 2045-2047, 1998.
19. Helzlsouer, K. J., Huang, H., Strickland, P. T., Hoffman, S., Alberg, A. J., Comstock, G. W., and Bell, D. A. Association between CYP17 polymorphisms and development of breast cancer. Cancer Epidemiol. Biomark Prev., 7: 945-949, 1998.
20. Hankinson, S. E., Manson, J. E., Spiegelson, D., Willett, W. C., Longcope, C., and Speizer, F. E. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol. Biomark. Prev., 4: 649-654, 1995.
21. Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., and Speizer, F. E. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J. Natl. Cancer Inst., 90: 1292-1299, 1998.
22. SAS Institute, Inc. SAS technical report p-229 SAS/STAT software. Changes and enhancements, release 6.07. Cary, NC: SAS Institute, Inc., 1992.
23. White, H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica, 48: 817-838, 1980.
24. SAS Institute, Inc. SAS/STAT user's guide, version 6., Ed. 4. Cary, NC: SAS Institute, Inc., 1989.
25. Franks, S., White, D., Gilling-Smith, C., Carey, A., Waterworth, D., and Williamson, R. Hypersecretion of androgens by polycystic ovaries: the role of genetic factors in the regulation of cytochrome P450c17α. Baillieres Clin. Endocrinol. Metab., 10: 193-203, 1996.
26. Rosenfield, R. L., Barnes, R. B., Cara, J. F., and Lucky, A. W. Dysregulation of cytochrome P450c17α as the cause of polycystic ovarian syndrome. Fertil. Steril., 53: 785-791, 1990.
27. Carey, A. H., Waterworth, D., Patel, K., White, D., Little, J., Novelli, P., Franks, S., and Williamson, R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum. Mol. Genet., 10: 1873-1876, 1994.
28. Kadonaga, J. T., Jones, K. A., and Tjian, R. Promoter-specific activation of RNA polymerase II transcription by Sp1. Trends Biochem. Sci., 11: 20-23, 1986.
29. Feigelson, H. S., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F., Z., and Henderson, B. E. Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res., 58: 585-587, 1998.